Icon has clinical protocols, formularies and funding models used by more than half the medical scheme market
Drugmaker is also considering partnership with a retail pharmacy to offer a collect option for customers
The ENSafrica investigation included interviews with hospital staff and a review of more than 120,000 emails and documents
The company is racing to increase output of the weight-loss drug Wegovy amid shortages
Drugmaker expects to finalise deals within the next six months to help use idle capacity
Payout is part of the proceeds of the sale of group’s interest in Alliance Medical Group
Grillenberger bought shares when Advanced Health was trading under a cautionary and without the required clearance
Pharmaceutical and biotechnology company outlines plans for experimental respiratory syncytial virus vaccine to offset decline in sales of its Covid vaccine
Novo Nordisk’s patents for Wegovy expire in China in 2026, in Japan and Europe in 2031 and in the US in 2032
HEPS rose 1%, benefiting from a buyback of 1.7-million shares due to a tough environment
Peter Wharton-Hood says shareholders preferred to get dividends rather than wait for long-term rewards
Alvotech settles with J&J to launch Stelara biosimilar in Europe and Canada
Firm returned the rights for its Alzheimer’s drug and had soft sales of its multiple sclerosis drug
Financial advisory firm BDO agrees with offer of 80c a share
The company plans to sell I-Mab Shanghai to affiliate Hangzhou for about $80m
The drugmaker's 2024 revenue outlook lifts shares
Amgen opts for a different route to weight-loss windfall rather than follow the drugmakers trying to emulate Eli Lilly's highly-effective Zepbound.
The Competition Commission recommends that the deal to acquire Fresenius Medical Care’s clinics be approved with conditions
There’s fear governments and funders are pulling back despite the potential to monitor infectious diseases better